New Delhi: In a major boost to India’s COVID vaccination drive, Sputnik V vaccine is likely to be available in the market by next week, Dr VK Paul, Member-Health of Niti Aayog said on Thursday. The first consignment of Russia’s Sputnik V COVID vaccine doses arrived in Hyderabad on May 1.The Sputnik V vaccine is Gam-COVID-Vac combined vector vaccine and is developed by the Gamaleya Research Institute of Epidemiology and Microbiology in Russia. Notably, the Sputnik V doses will be manufactured in India from July.The Drugs Controller General of India (DCGI) granted permission for restricted use in emergency situations to Sputnik V vaccine in April. Dr. Reddy’s Laboratories Ltd had applied for the grant of permission to import and market Sputnik V for emergency use authorisation. “The vaccine is indicated for active immunization to prevent COVID-19 disease in individuals of ≥ 18 years of age. The vaccine should be administered intramuscularly in two doses of 0.5 ml each with interval of 21 days. (Day 0: Component I & Day 21: Component II). The vaccine has to be stored at -18°C,” the Ministry of Health and Family Welfare had stated in its statement.Making a major announcement, Paul said that over two billion coronavirus vaccine doses will be made available in India between August and December."Over two billion doses will be made in the country in five months (August to December) for India and for the people of India. The vaccine will be available for all as we move forward," Paul said.Giving details of the upcoming vaccine doses, the NITI Aayog member said, Biological E is likely to produce 30 crore doses, Sputnik V 15.6 crore doses, Zydus Cadila 5 crore, Serum Institute of India 20 crore doses of Novavax, Bharat Biotech 10 crore doses of its nasal vaccine, while Gennova will provide 6 crore doses.